Spine FA3 - a Prospective, International, Multicenter Cohort Study on Treatment of of AO A3 Thoracolumbar Fractures
NCT ID: NCT01751633
Last Updated: 2020-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
38 participants
OBSERVATIONAL
2013-01-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment
NCT02827214
Surgical Treatment of the Thoracolumbar Spine Fractures.
NCT03316703
Randomized Trial With an Observational Component of Non-operative Versus Operative Treatment for AO Type A3 Fractures
NCT02179697
Comparison of Short Segment Mono-axial and Poly-axial Pedicle Screw Fixation for Thoracolumbar Fractures
NCT04032054
Thoracic And Lumbar Burst Fracture: Correlation Between Structural Changes And Clinical Outcome Of Treatment
NCT02076607
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical treatment
Surgical treatment according to one of the following:
* Posterior open approach
* Posterior minimally-invasive surgery (MIS) approach The choice of the approach will be left upon the surgeon's discretion
Surgical
Conservative treatment
Conservative treatment according to hospital's standard of care
Conservative treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgical
Conservative treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of single or multiple stable thoracolumbar fracture(s)
* Level T10- L3
* Type AO A3 or A4
* Radiologically confirmed by Rx or CT
* Fracture induced kyphotic deformity lower or equal to 20-35 degrees
* Definitive treatment (surgical or conservative) within 10 days after injury
* American Spinal Injury Association (ASIA) Impairment Scale = E (normal )
* Ability to understand patient information / informed consent form
* Willingness and ability to participate in the clinical investigation including imaging and follow-up procedures (FUs)
* Signed informed consent
Exclusion Criteria
* Polytrauma
* Pathologic fracture
* Disruption of the posterior ligamentous complex between T10 and L3
* Clinically evident osteoporosis as assessed by the investigator
* Spinal luxation
* Associated severe lesions as assessed by the investigator
* Spinal lesion due to gun or projectile
* Pre-existing spinal column deformity
* Prior spinal surgeries
* BMI \> 40 kg/m2
* Any severe medically not managed systemic disease
* Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reli-able assessment
* Pregnancy or women planning to conceive within the study period
* Prisoner
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AO Clinical Investigation and Publishing Documentation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giuseppe Barbagallo, MD
Role: PRINCIPAL_INVESTIGATOR
Azienda Ospedaliero - Universitaria Policlinico, Catania, Italy
Emiliano Vialle, MD
Role: PRINCIPAL_INVESTIGATOR
Catholic University of Parana - Curitiba, Brazil
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitaria Cajuru
Curitiba, , Brazil
Hospital Cristo Redentor
Porto Alegre, , Brazil
Hospital Santa Marcelina
São Paulo, , Brazil
Hospital Cristo Redentor
Santiago, , Chile
Krajská nemocnice Liberec
Liberec, , Czechia
Klinikum rechts der Isar der Technischen Universität München
Munich, , Germany
Azienda Ospedaliero - Universitaria Policlinico
Catania, , Italy
Hospital Garcia e Orta, EPE
Almada, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Spine FA3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.